- 1Department of Vascular and Endovascular Surgery, Torrecardenas University Hospital, Almeria, Spain
- 2Department of Vascular and Endovascular Surgery, Cabueñes University Hospital, Gijon, Spain
- 3Department of Otorhinolaryngology – Head and Neck Surgery, Research Program in Systems Oncology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland
- 4Department of Otorhinolaryngology, University of Oviedo, Oviedo, Spain
- 5Department of Surgical Oncology, Medical School of Crete University Hospital, Heraklion, Greece
- 6Department of Otorhinolaryngology, Medical School of Crete University Hospital, Heraklion, Greece
- 7Department of Otorhinolaryngology and Head and Neck Surgery, Radboud University Medical Center, Nijmegen, Netherlands
- 8Department of Radiotherapy, Institute of Oncology, Ljubljana, Slovenia
- 9ENT Unit, Policlinico Città di Udine, Udine, Italy
- 10Coordinator of the International Head and Neck Scientific Group, Padua, Italy
Intravenous lipomas (IVLs) of the head and neck are uncommon benign tumors that develop within the venous walls, often detected incidentally during imaging for unrelated issues. While usually asymptomatic, these IVLs can cause congestive venous symptoms like swelling, paresthesia or pain in the head and neck and upper limbs, or even venous thromboembolism. The precise diagnosis of IVLs is predominantly achieved through computed tomography (CT) and magnetic resonance imaging (MRI), with CT being the most frequently used method. Symptomatic patients generally undergo open surgery with excision of the IVL followed by venous reconstruction, which has shown safe and effective outcomes. However, the management of asymptomatic IVLs remains controversial due to the limited number of reported cases. Despite this, there is a notable trend toward recommending surgical removal of IVLs to prevent complications and rule out malignancy, driven by the challenges of differentiating IVLs from malignant tumors using imaging alone. This review highlights the key differential imaging characteristics of IVLs and the main surgical techniques to remove the tumor and repair the vascular defect. Further research is necessary to establish a robust, evidence-based approach for treating asymptomatic IVLs, balancing the risks of surgery against the potential for future complications.
1 Introduction
Lipomatous tumors in the head and neck region are rare, exhibiting a wide spectrum of biological behaviors, from completely benign to malignant with metastatic potential. Ordinary lipoma, the most prevalent benign tumor in adults, constitutes approximately 30–50% of all soft tissue tumors and predominantly occur in the subcutaneous tissue of the upper body and proximal extremities (1–4), with around 13–17% located in the head and neck region (1). However, intravenous lipomas (IVLs) are extremely rare primary venous tumors originating intravascularly. While these lipomas are most commonly found in the heart (5), their occurrence in central veins is exceptionally uncommon (6). The inferior vena cava (IVC) is the most common location for IVLs, with few cases reported in the head and neck region (6). Many IVLs are asymptomatic and are often discovered during imaging studies for other conditions, while others mimic deep vein thrombosis by causing compressive or occlusive symptoms (5, 7–9). Although IVLs have a favorable prognosis, their clinical course is not well understood. Due to the scarcity of reported cases, the indication for surgical intervention is controversial, particularly in asymptomatic patients, given the uncertain risk of thrombus formation, venous occlusion, and embolization. The aim of this mini-review is to clarify the natural history and optimal management strategies for IVL, thereby enhancing clinical decision-making and patient outcomes. Key points for imaging diagnosis are summarized, surgical techniques are briefly outlined, and associated patient outcomes are presented.
2 Literature review, primary anatomical locations, and demographic trends
A literature search was conducted across three major databases (PubMed, Elsevier, Google Scholar) using the terms “lipoma” AND (“intravascular” OR “intravenous” OR “superior vena cava” OR “brachiocephalic” OR “subclavian” OR “jugular”). If additional studies were identified from the references of previously published reviews, they were included in the analysis.
Only 24 cases of IVL were identified until May 2024 during the above literature search.
The majority of reported IVL cases in the head and neck region involved the superior vena cava (SVC), often extending to the brachiocephalic, subclavian or jugular veins (2, 4, 6–17). IVLs may also occur within the SVC without extension to adjacent veins (18–22). Additionally, isolated cases of jugular (5) or brachiocephalic vein lipomas (23–27) have also been documented. With the exception of cases reported by Kamdar et al. (11) and Fung (27), right-sided veins are typically involved. Regarding gender distribution, IVLs exhibited a male predominance with a ratio of 3:1 compared to females, while they are detected at an earlier age in women (mean age: 53.2 years, range: 39–70 years) compared to men (mean age: 58.5 years, range: 47–73 years) (2, 4–27). The occurrence rate of IVLs is unknown but it was estimated to be found, as an incidental finding, in 0.35–0.5% among the general population undergoing contrast-enhanced CT (4, 28).
Table 1 summarizes the case reports from the literature describing IVLs involving the SVC and cervical veins.
3 Pathophysiological mechanisms and potential contributing factors
The risk factors for IVLs remain somewhat unclear due to the limited literature on this condition and the absence of experimental data. However, several authors have suggested that obesity, liver cirrhosis, hepatic tumors, renal angiomyolipomas, direct venous injury, and prolonged corticosteroid use may be associated with the presence of IVLs (7, 13, 29, 30).
Genetic factors are believed to play a significant role. However, while approximately 7–14% of patients with ordinary lipomas develop multiple lipomas, familial multiple lipomas are observed in about 30% of cases (1), suggesting a hereditary predisposition, only Thorogood et al. (8) have reported a case of SVC IVL associated with multiple cutaneous lipomas.
Santos et al. (13) have proposed a hypothesis regarding the potential role of immunologic phenomena associated with sarcoidosis, which could impact the structural components of vessel walls. This hypothesis is based on the plausible differentiation of vascular wall-resident multipotent stem cells, including mesenchymal stem cells, into adipocytes. Despite the few adipocytes typically present in the venous media layer, according to their assumption, these factors may contribute to the abnormal growth of fatty tissue within veins.
4 Natural history of IVLs and variants
4.1 Natural progression of IVLs
Several hypotheses have been proposed about the origin of IVLs. Initially, IVLs were believed to originate within the vein wall, with potential expansion into the vascular lumen or extraluminal invasion into surrounding adipose tissue (2, 6, 9, 13, 22). The first documented case of an IVL dates to 1962, reported by Tsardakas, involving the endothelium of the saphenous vein (31). However, subsequent reports by other authors have depicted cases where lipomas exhibited both intravascular and extravascular components (4, 5, 24). This duality has prompted the formulation of two theories to elucidate this peculiar presentation, positing intraluminal origin from the vein wall or extraluminal origin via invagination of adjacent adipose tissue (13). According to the former theory, the tumor grows into the vein wall protruding both internally and externally (4, 13, 23, 24, 29, 30, 32). The latter hypothesis suggests a perivascular tissue origin, infiltration into the vein wall, and subsequent protrusion into the lumen. Lomeo et al. (4) provided a detailed description of how the tumor arose from perivascular tissue and then intruded into the vein by invagination without infiltrating the wall. The CT scan revealed that initially, the mass was located outside the right subclavian vein; however, after a 2 cm distance, it traversed the venous wall and positioned itself within the vein lumen as it approached the SVC. The transmural vascular invasion of the IVL into the vein was described as a dumbbell-shaped extension of the tumor (24).
4.2 Pericaval fat collections as normal variants
Concerning fat mass-like lesions, localization adjacent to or projecting into the subdiaphragmatic portion of the intrahepatic IVC is recognized as a normal variant by some authors (28). Miyake et al. (28) first described these focal fat collections in 1992, found in 0.5% of 2,227 patients undergoing a CT examination. Subsequently, Perry et al. (30) reported similar findings in seven cases, terming them “lipomas.” Although these masses appeared intraluminal due to their acute angle with respect to the cava wall, speculation persisted regarding their external origin (30). Han et al. (33) attributed the appearance of pericaval fat collections to rightward angulation of the IVC and narrowing of the intrahepatic IVC. The stability of fat collections on follow-up CT scans in the majority of reported cases supports the notion that these findings likely represent entirely extraluminal lesions mimicking intraluminal masses. Thus, they are considered unusual but normal variants with no clinical significance, negating the need for patient follow-up (34).
5 Clinical presentation: how IVLs show up
IVLs are often asymptomatic and are commonly detected incidentally during imaging studies conducted for unrelated reasons (8, 9). When symptoms do occur, they are usually attributable to the location and tumor’s size, resulting in venous thrombosis, obstructive venous symptoms, or mediastinal syndromes due to compressive effects (6, 21, 23). Although SVC lipomas or IVLs in the head and neck region are rare compared to IVC counterparts, they may produce symptoms related to venous obstruction within the SVC drainage territory. This can manifest as SVC syndrome, swelling in the head, face, neck, and arms, as well as upper limb paresthesia, shoulder pain, and venous thromboembolism (6, 7, 12, 15, 17, 18, 21). In the literature review, only 21% of cases were associated with symptoms (6, 16–18, 21). Among them, facial and upper extremity edema have been reported as the main symptom of head and neck IVLs.
In cases involving larger IVLs within the SVC, there have been reports of intraluminal thrombus formation, such as the case documented by Bravi et al. (18) where an IVL within the SVC led to a subtotal occlusion extending into the right atrium, accompanied by thrombosis of the suprahepatic IVC and the portal vein. Similarly, Lococo et al. (24) reported a case of a fatty neoplastic thrombus completely occluding the brachiocephalic vein. It is postulated that the subsequent turbulent flow may promote thrombus formation and occlusion (18, 30).
6 Diagnostic imaging of IVLs and histopathologic findings
6.1 Key imaging features of IVLs
IVLs can be diagnosed using various imaging modalities, including sonography, CT, MRI, transthoracic/transesophageal echocardiogram, or venography (16). Among reported cases of IVLs in the head and neck region, CT and MRI are commonly employed for characterizing the mass (1).
Upon examination of chest X-rays, the identification of a widened superior mediastinum may signal the presence of a SVC IVL, as documented by Vinnicombe et al. (6). Sonographically, IVLs typically present as intraluminal hyperechoic masses with or without thin septa. Duplex venous sonography can show a patent vein or diminished flow if the lipoma is causing near obstruction (4, 9, 16, 25). However, MRI and CT are the most reliable imaging techniques for confidently identifying adipose tissue in these lesions (1). CT imaging may depict a well-defined, hypoattenuating intraluminal mass consistent with fat, often lacking contrast enhancement except for its fibrous capsule (1, 16, 35) (Figures 1A,B). Contrast CT is particularly effective in determining fat coefficients by calculating Hounsfield units (HU) with given values between −30 to −150 HU, facilitating non-invasive diagnosis of IVLs in major venous vessels (9, 36). CT also aids in distinguishing lipomas from other soft tissue tumors based on fat density and also in identifying the presence of an intravenous thrombus by calculating the densitometry of the intraluminal mass (36, 37). CT has been performed in all reported cases of IVL except the one reported by Wahab et al. (22). This case involved the superior vena cava and right atrium and was diagnosed using only MRI and echocardiography. On MRI, IVLs appear as well-circumscribed lesions with signal characteristics similar to subcutaneous fat across all imaging sequences. Fat-specific MRI sequences appear to offer the highest specificity for diagnosing IVLs compared to other modalities confirming their fatty nature through significant loss of signal intensity on fat suppression sequences. They exhibit high signal intensity on T1-weighted images and also on T2-weighted images, although the intensity on T2-weighted images may be slightly lower compared to T1-weighted images (16, 38) (Figure 1C). However, MRI was performed in less than the half of the reported cases (2, 8, 10–12, 14, 15, 18, 21–23, 25).
![www.frontiersin.org](https://www.frontiersin.org/files/Articles/1447960/fneur-15-1447960-HTML/image_m/fneur-15-1447960-g001.jpg)
Figure 1. Axial (A) and coronal (B) images of a CT scan of the chest, revealing a 10 mm, well-defined, hypodense mass at the right jugulosubclavian venous confluence (white arrows). This lesion is consistent with the characteristics of an intravascular lipoma, exhibiting fat attenuation (-97 HU) and no evidence of significant contrast enhancement. On an axial T2-weighted MRI sequence without fat saturation (C), the lipoma appears as a hyperintense, homogeneous mass.
6.2 Additional imaging modalities
In addition to standard imaging techniques, other modalities can offer valuable insights into the diagnosis and characterization of IVLs. Transthoracic and transesophageal echocardiography can provide useful tissue information, including echogenicity, calcification, vascularity, and evaluation of right atrium extension, aiding in the diagnosis of lipomas (2). Nonetheless, echocardiography was performed in only 4 of the total reported cases. Another imaging technique which may demonstrate a filling defect in the SVC or jugulosubclavian venous confluence with collateral development is the SVC venography (6, 12). Due to its invasiveness and limited value compared to CT or MRI, venography is not commonly used. Additionally, fludeoxyglucose positron emission tomography (FDG-PET) is suggested as a technique which can aid in differentiating malignant from benign lipomatous tumors and between different liposarcoma subtypes, though its use in IVLs of the head and neck has not been reported (1).
6.3 Histopathological analysis of IVLs
IVLs are characterized by distinctive histological features. Macroscopically, IVLs present as well-circumscribed, pale yellow, lobulated fatty masses occupying the vein lumen, which may or may not be associated with thrombus formation (5, 6). Microscopically, IVLs exhibit well-differentiated tumor predominantly composed of mature white adipose cells with non-centrally located nuclei and thin fibrous septa in some areas, encapsulated by collagenous tissue. IVLs typically lack necrosis, hemorrhage, or calcifications (14, 15).
6.4 Differential diagnosis
In addition to lipomas, the differential diagnosis of intravascular masses containing fat encompasses a spectrum of benign and malignant conditions such as thrombus formation, other primary tumors, and secondary tumor extension (39).
Among benign tumors, leiomyomas, originating from smooth muscle cells of the endothelium, represent the most prevalent venous tumors (3, 4). Another benign entity, fibrolipoma, characterized by neoplastic fat cells within dense collagen, has been reported, including a unique case involving the femoral vein (40). Hemangiomas, deriving from endothelial cells, have also been documented, with Hu et al. (41) reporting a rare case of a massive unicameral cardiac hemangioma associated with a persistent left SVC.
Among malignant tumors, leiomyosarcomas, arising from smooth muscle tissue of the endothelium, are the most common primary tumors of the vena cava, often leading to luminal obliteration (30). Fibrosarcomas, originating from connective tissues, and endotheliomas and hemangioendotheliomas, derived from endothelial cells, are also to be considered. Although venous angiosarcomas are rare, reported cases suggest their potential presence, characterized by mesenchymal cells with epithelioid morphology, focal nuclear atypia in adipocytes, vascular channels, and CD31 endothelial marker positivity (42). Liposarcoma, the malignant variant of lipoma, typically appear on CT as heterogeneous masses with areas of fat density interspersed with soft tissue density. They usually include thick septa and nodular or globular areas of non-adipose tissue that show heterogeneous patterns of signal intensity and enhancement due to necrosis, hemorrhage, myxoid changes or cellular areas. On T1-weighted images generally exhibit intermediate to low signal intensity and tend to show heterogenous high signal intensity on T2-weighted images. Fat-suppressed sequences and gadolinium-enhanced sequences can show heterogeneous enhancement, reflecting areas of vascularization and necrosis (35, 38). Cytogenetic analysis may play a crucial role in establishing the diagnosis (1). Head and neck intravenous location of liposarcoma has not been reported in the literature so far (26).
7 Management of IVLs: from observation to intervention
7.1 Surgical and non-surgical treatment options
Treatment guidelines for IVLs have not yet been established, most likely due to their rarity. Given that most IVLs are asymptomatic and exhibit slow growth, some authors suggest that invasive treatment may not be necessary for asymptomatic cases (2, 8–10, 13, 23, 25, 26, 36). However, regular follow-up with imaging examinations is essential to monitor any changes in the tumor over time (38). Nevertheless, other authors state that surgical resection is crucial to rule out malignancies and prevent the potential risk of thrombus formation, embolization, penetration of the right atrium and venous occlusion (2, 12, 17). This viewpoint supports the surgical removal of asymptomatic IVLs, particularly when the patient is fit for surgery and the lesion’s location allows for a safe approach without risking damage to nearby structures, thereby making the risk–benefit balance favorable in these cases (2, 12, 17, 18). This is especially recommended for large lipomas or those that are mobile, as they pose a risk for future pulmonary thromboembolism (43). Another factor endorsing this position is that, despite no reported cases of intravenous liposarcoma in the literature (26), surgical management in asymptomatic patients may be necessary to exclude malignancy in scenarios where CT or MRI cannot reliably differentiate between benign lipomas and well-differentiated liposarcomas (2), or where the lesion displays radiologic features of vascular invasiveness and association with a fatty thrombus, which are highly suggestive of malignancy. Surgical excision not only provides a definitive histological diagnosis but also prevents these risks, with no major complications reported in the performed surgeries. Furthermore, Mordant and colleagues argue that excision should be mandatory since surgical treatment is safe without the need of lifelong anticoagulation (12, 20).
Management of IVLs in other regions varies. Although no published reports exist on tumor resection for IVLs of the IVC (29, 36, 43, 44), half of the cases involving the renal vein have undergone surgery (35, 45). Additionally, all published cases of iliofemoral IVLs have been treated with surgical resection (3, 32, 40, 46–48).
7.2 Surgical excision techniques
The surgical approach for excising IVLs in the head and neck should be carefully considered and supported by adequate preoperative anatomical imaging. Its primary challenge is the proximity of relevant anatomical structures, therefore, when planning intervention, it is crucial to balance achieving complete tumor removal with minimizing the risk of complications and unnecessary functional and cosmetic morbidity (1).
The resection techniques described in the literature vary depending on the anatomical localization and extent of the tumor. It should also be noted that some published cases do not describe the surgical technique employed. Nonetheless, a median sternotomy combined with transcervical approach has been the most frequently used surgical approach, as it allows control of all major thoracic veins, minimizes the risk of tumor embolization, limits blood loss, and permits en bloc resection of the tumor if necessary (2, 4, 12, 16, 17, 24). Some reports describe the use of cardiopulmonary bypass to excise SVC IVLs when they extend into or are proximal to the right atrium (14–16, 18, 22).
To remove the IVL, a longitudinal (6, 16) or transverse (12) venotomy can be performed, and the tumor can then be pulled down and excised (6, 11, 18). The venous wall may be primary repaired with a running 6/0 or 7/0 polypropylene suture (4) or using a patch of polytetrafluoroethylene (24) or pericardium for surgical defect closure (2, 18). Another method for tumor removal is en bloc resection followed by end-to-end anastomosis between the two severed venous ends (12) or, in cases of IVLs isolated in the internal jugular vein, by ligation (5, 11).
Special mention is given to Cohen et al. (2), who planned a hybrid approach for an IVL extending from the jugular and subclavian vein to the SVC. They performed an endovascular technique to control the right brachiocephalic vein via the right brachial vein with a 12 mm balloon prior to venotomy to prevent the risk of tumor embolization and minimize blood loss during the en bloc excision of the IVL.
7.3 Post-treatment outcomes and follow-up
Among the 16 surgical patients reported in the literature, the administration of antiplatelet agents (2, 5, 21) or anticoagulants (4, 16, 18, 22) in the immediate postoperative period is noted in only 7 cases, as well as in the non-surgical case reported by Santos et al. (13), associated with sarcoidosis and long-term corticosteroid therapy.
Most cases after surgical removal had an uneventful recovery. Two postoperative complications were reported: a pulmonary embolism one week after discharge (21) and Dressler’s syndrome on postoperative day 25 (2).
Short-term follow-up imaging should be considered to assess for central vein stenosis or occlusion. Notably, many authors did not specify the surveillance regimen, and those who did typically indicated short-term follow-up with an average duration of 10 months (range 1–36 months) (2, 4, 5, 7, 12–16, 18). No evidence of tumor recurrence was observed during follow-up. Based on this, Sundaram et al. (16) suggested that due to the low incidence of tumor recurrence, long-term follow-up does not appear to be necessary.
8 Conclusion
IVLs represent rare benign neoplasms that grow into the venous wall. While often asymptomatic, they have the potential to induce congestive venous symptoms and venous thromboembolism. CT and MRI are the most valuable imaging techniques for confident identification of IVLs, with CT being the most frequently used throughout the literature. For symptomatic patients, surgical excision via median sternotomy and cervicotomy with subsequent venous reconstruction represents the main treatment strategy. The management of asymptomatic patients, however, remains controversial due to the limited number of reported cases. Despite this, our mini-review underscores a prevailing trend toward the surgical removal of IVLs. This inclination is driven by the necessity to accurately exclude malignancy based on cross-sectional imaging alone and to mitigate the risks of venous thromboembolism, particularly in larger or mobile lipomas. Our findings highlight that this proactive approach is substantiated by a remarkably low complication rate and the documented absence of recurrence following surgical excision. Further research is needed to accurately determine the real risk of complications and morbidity in asymptomatic IVL patients in order to establish an evidence-based approach for individual treatment selection.
Author’s note
This article was written by members and invitees of the International Head and Neck Scientific Group (http://www.ihnsg.com).
Author contributions
VF-A: Writing – review & editing, Writing – original draft, Visualization, Validation, Supervision, Software, Project administration, Methodology, Investigation, Formal analysis, Data curation, Conceptualization. ML-S: Software, Writing – review & editing, Writing – original draft, Investigation, Data curation. AM: Writing – review & editing, Writing – original draft. CS: Writing – review & editing, Writing – original draft. EB: Writing – review & editing, Writing – original draft. AK: Writing – review & editing, Writing – original draft. RT: Writing – review & editing, Writing – original draft. PS: Writing – review & editing, Writing – original draft. AR: Writing – review & editing, Writing – original draft. AF: Project administration, Writing – review & editing, Writing – original draft, Visualization, Validation, Supervision.
Funding
The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
1. de Bree, E, Karatzanis, A, Hunt, JL, Strojan, P, Rinaldo, A, Takes, RP, et al. Lipomatous tumours of the head and neck: a spectrum of biological behaviour. Eur Arch Otorrinolaringol. (2015) 272:1061–77. doi: 10.1007/s00405-014-3065-8
2. Cohen-Mussali, S, Leon, M, Rey-Rodriguez, A, Canalizo, E, Yebra-Lopez, A, Gómez-González, MD, et al. Surgical resection of an intravascular lipoma of the superior vena cava. Vasc Endovasc Surg. (2023) 57:169–74. doi: 10.1177/15385744221130862
3. Al-Omran, M, and Kucey, DS. Intravascular lipoma of the left common femoral vein. J Vasc Surg. (2001) 33:1104–7. doi: 10.1067/mva.2001.111995
4. Lomeo, A, D'Arrigo, G, Scolaro, A, Mudano, M, Monea, MC, Mauceri, G, et al. A case of intra and extra-vascular lipoma of the subclavian vein. EJVES Extra. (2007) 13:37–9. doi: 10.1016/j.ejvsextra.2006.08.003
5. Yoon, RH, Buzas, CJ, Garvin, RP, and Franklin, DP. Intravascular lipoma of the internal jugular vein. J Vasc Surg Venous Lymphat Disord. (2013) 1:406–8. doi: 10.1016/j.jvsv.2012.12.004
6. Vinnicombe, S, Wilson, AG, Morgan, R, and Saunders, K. Intravascular lipoma of the superior vena cava: CT features. J Comput Assist Tomogr. (1994) 18:824–7. doi: 10.1097/00004728-199409000-00026
7. Beliaev, A, Bergin, C, Hill, AA, Chaudhuri, K, and Haydock, D. Investigation and surgical treatment of a superior vena cava lipoma. ANZ J Surg. (2020) 90:E85–6. doi: 10.1111/ans.15313
8. Thorogood, SV, and Maskell, GF. Case report: intravascular lipoma of the superior vena cava-CT and MRI appearances. Br J Radiol. (1996) 69:963–4. doi: 10.1259/0007-1285-69-826-963
9. Knop, G, Margaria, RA, Feroglio, S, Margaria, M, and Margaria, R. Intravascular lipoma of the superior vena cava: case report. Radiology open Acc J. (2021) 1:1–4.
10. Ryu, SR, Park, JY, Riy, YS, Yu, YH, Yang, DJ, Lee, BH, et al. Intravascular lipoma of the right subclavian vein. Tuberc Respir Dis. (2009) 67:154–7. doi: 10.4046/trd.2009.67.2.154
11. Kamdar, DV, Chopra, S, Lin, HS, Treadway, C, Robinette, N, Herawi, M, et al. Intravascular lipoma of the left internal jugular vein. Otolaryngol Head Neck Surg. (2009) 141:156–7.
12. Mordant, P, Mercier, O, Fadel, E, Muniappan, A, Fabre, D, Chataigner, O, et al. Surgical resection of an intravascular superior vena cava primary lipoma. J Thorac Cardiovasc Surg. (2010) 140:1437–8. doi: 10.1016/j.jtcvs.2009.04.072
13. Santos, LA, Santos, VM, Pitol, DN, and Dualibi, DF. Intravenous lipoma and pulmonary sarcoidosis treated with prednisone. An Sist Sanit Navar. (2012) 35:317–22. doi: 10.4321/s1137-66272012000200014
14. Elen, E, D'Angelo, T, Tjubandi, A, and Raharjo, SB. A rare case of superior vena cava lipoma: its presentation from non-invasive examination. Eur Heart J Cardiovasc Imaging. (2019) 20:1183. doi: 10.1093/ehjci/jez085
15. Soetisna, TW, Namretta, L, Ronidipta, B, Elen, E, Raharjo, SB, and Tjubandi, A. Giant lipoma in superior vena cava: A case report and literature review. Int J Surg Case Rep. (2022) 95:107142. doi: 10.1016/j.ijscr.2022.107142
16. Sundaram, N, Kulkarni, R, Sultan, I, and Singh, MJ. Surgical resection of a symptomatic superior vena cava lipoma: a case report and literature review. Ann Vasc Surg. (2021) 71:535.e11–5. doi: 10.1016/j.avsg.2020.09.052
17. Podobed, A . Intravascular lipoma of the right brachiocephalic vein and superior vena cava: a case report and literature review. Georgian Med News. (2021) 311:33–6.
18. Bravi, MC, Salvadei, S, Scarponi, P, Loforte, A, Musumeci, F, and Gasbarrone, L. Intravascular lipoma of the superior vena cava. Intern Emerg Med. (2012) 7:79–81. doi: 10.1007/s11739-011-0584-9
19. Trabut, JB, Duong Van Huyen, JP, Artru, B, and Bruneval, P. Lipome intravasculaire de la veine cave supérieure [Intravascular lipoma of the superior vena cava]. Ann Pathol. (1999) 19:529–31.
20. Concatto, NH, Camargo, S, Camargo, J, Hochhegger, B, Irion, K, and Marchiori, E. Superior vena cava lipoma in an asymptomatic man. Lung. (2015) 193:847–9. doi: 10.1007/s00408-015-9773-z
21. Tanyeli, Ö, Dereli, Y, Görmüş, N, and Ödev, K. Primary intravascular lipoma of the superior vena cava. Balkan Med J. (2015) 32:333–4. doi: 10.5152/balkanmedj.2015.15808
22. Wahab, A, Chaudhary, S, Munir, A, and Smith, SJ. Lipoma of superior vena cava: a rare occurrence. BMJ Case Rep. (2017) 2017:bcr2017220641. doi: 10.1136/bcr-2017-220641
23. Moore, FO, Petersen, SR, and Norwood, SH. Intravascular lipoma of the right innominate vein in a trauma patient. J Am Coll Surg. (2008) 207:139. doi: 10.1016/j.jamcollsurg.2007.10.015
24. Lococo, F, Brandolini, J, Hamelin-Canny, E, Charpentier, MC, and Alifano, M. Lipoma of the right thoracic inlet with intravascular extension and fatty thrombus into the right brachiocephalic vein. Ann Thorac Surg. (2013) 95:e129. doi: 10.1016/j.athoracsur.2012.10.053
25. Iqbal, N, and Tiwari, A. Lipoma in the brachiocephalic vein. Eur J Vasc Endovasc Surg. (2017) 53:694. doi: 10.1016/j.ejvs.2017.01.019
26. Vetrhus, M, and Fjetland, L. Intravenous lipoma. Tidsskr Nor Laegeforen. (2017) 137:137. doi: 10.4045/tidsskr.17.0646
27. Fung, T . Intravascular lipoma of the brachiocephalic vein. Case study. (2023). doi: 10.53347/rID-97705
28. Miyake, H, Suzuki, K, Ueda, S, Yamada, Y, Takeda, H, and Mori, H. Localized fat collection adjacent to the intrahepatic portion of the inferior vena cava: a normal variant on CT. AJR Am J Roentgenol. (1992) 158:423–5. doi: 10.2214/ajr.158.2.1729801
29. Grassi, R, Di Mizio, R, Barberi, A, Severini, S, Del Vecchio, A, Cappabianca, S, et al. Ultrasound and CT findings in lipoma of the inferior vena cava. Br J Radiol. (2002) 75:69–71. doi: 10.1259/bjr.75.889.750069
30. Perry, JN, Williams, MP, Dubbins, PA, and Farrow, R. Lipomata of the inferior vena cava: a normal variant? Clin Radiol. (1994) 49:341–2. doi: 10.1016/s0009-9260(05)81802-1
31. Tsardakas, E, and Gomatopoulos, I. Discovery of a lipoma of the endothelium of the saphenous vein causing obstruction and venous stasis. Hell Cheirourgike. (1962) 9:181–5.
32. McClure, MJ, Sarrazin, J, Kapusta, L, Murphy, J, Arenson, AM, and Geerts, W. Intravascular femoral vein lipoma: an unusual cause of lower limb venous obstruction. AJR Am J Roentgenol. (2001) 176:463–4. doi: 10.2214/ajr.176.2.1760463
33. Han, BK, Im, JG, Jung, JW, Chung, MJ, and Yeon, KM. Pericaval fat collection that mimics thrombosis of the inferior vena cava: demonstration with use of multi-directional reformation CT. Radiology. (1997) 203:105–8. doi: 10.1148/radiology.203.1.9122375
34. Katz, DS, and Goffner, L. "lipoma" of the inferior vena cava is actually a pericaval fat collection. J Clin Ultrasound. (2002) 30:57–8. doi: 10.1002/jcu.10020
35. Doyle, Z, Wolford, B, Morshedi, MM, and Santillan, CS. Intravascular lipoma of the renal vein. BJR Case Rep. (2015) 1:20150072. doi: 10.1259/bjrcr.20150072
36. Chou, YH, Chiou, HJ, Tiu, CM, Chiang, JH, Chang, CY, and Yu, C. Sonographic appearance of lipoma of the inferior vena cava. J Clin Ultrasound. (2001) 29:359–62. doi: 10.1002/jcu.1049
37. Schranz, AL, Riordan, F, Dolan, R, Lawlor, C, Morrison, C, O'Toole, G, et al. Retrospective analysis of radiological investigation of surgically excised head and neck lipomas. Eur Arch Otorrinolaringol. (2024) Epub ahead of print) 281:4333–9. doi: 10.1007/s00405-024-08672-3
38. Kransdorf, MJ, Bancroft, LW, Peterson, JJ, Murphey, MD, Foster, WC, and Temple, HT. Imaging of fatty tumors: distinction of lipoma and well-differentiated liposarcoma. Radiology. (2002) 224:99–104. doi: 10.1148/radiol.2241011113
39. Hines, J, Katz, DS, Goffner, L, and Rubin, GD. Fat collection related to the intrahepatic inferior vena cava on CT. AJR Am J Roentgenol. (1999) 172:409–11. doi: 10.2214/ajr.172.2.9930793
40. Jiang, C, Ni, L, Liu, C, Jia, C, Wu, X, Wang, J, et al. Intravascular fibrolipoma of the femoral vein. Ann Vasc Surg. (2017) 39:287.e7–287.e13. doi: 10.1016/j.avsg.2016.06.039
41. Hu, W, Wang, X, Tan, S, Fan, S, Liu, J, Yu, F, et al. Large hemangioma in a persistent left superior vena cava. Thorac Cardiovasc Surg. (2012) 60:e3–5. doi: 10.1055/s-0032-1330995
42. Abratt, RP, Williams, M, Raff, M, Dodd, NF, and Uys, CJ. Angiosarcoma of the superior vena cava. Cancer. (1983) 52:740–3. doi: 10.1002/1097-0142(19830815)52:4<740::aid-cncr2820520429>3.0.co;2-p
43. Koike, H, Suzuka, M, Morikawa, M, Sueyoshi, E, and Uetani, M. Intravascular lipoma of the inferior vena cava and left renal vein. Radiol Case Rep. (2021) 16:1233–6. doi: 10.1016/j.radcr.2021.02.070
44. Cabri-Wiltzer, M, and Danse, E. Benign lipoma of the inferior vena cava. JBR-BTR. (2013) 96:212–3. doi: 10.5334/jbr-btr.280
45. Succar, B, Abuhakmeh, Y, Khreiss, M, and Zhou, W. Mobile primary renal vein lipoma with an acelerated growth pattern. J Vasc Surg Cases Innov Tech. (2022) 8:670–3. doi: 10.1016/j.jvscit.2022.09.007
46. Clemente, M, Romagnuolo, R, Dumani, X, De Rosa, D, and Renda, A. Intravascular lipoma from iliofemoral tract. Updat Surg. (2010) 62:207–9. doi: 10.1007/s13304-010-0028-5
47. Donato, F, Annuvolo, PA, Lupascu, A, Donati, T, Tinelli, G, and Tshomba, Y. Images in vascular medicine: intravascular lipoma of a common femoral vein – an uncommon cause of recurrent deep vein thrombosis. Vasc Med. (2022) 27:606–8. doi: 10.1177/1358863X221115214
Keywords: lipoma, intravenous lipoma, primary venous tumor, superior vena cava, head and neck
Citation: Fernández-Alvarez V, Linares-Sánchez M, Mäkitie AA, Suárez C, de Bree E, Karatzanis A, Takes RP, Strojan P, Rinaldo A and Ferlito A (2024) Intravenous lipomas of head and neck: an exceptional entity and its clinical implications. Front. Neurol. 15:1447960. doi: 10.3389/fneur.2024.1447960
Edited by:
Wayne Yakes, The Yakes Vascular Malformation Center, United StatesReviewed by:
Osamah Alwalid, Sidra Medicine, QatarCopyright © 2024 Fernández-Alvarez, Linares-Sánchez, Mäkitie, Suárez, de Bree, Karatzanis, Takes, Strojan, Rinaldo and Ferlito. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Verónica Fernández-Alvarez, UO72421@uniovi.es